Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Felip Font, Enriqueta
260  Ergebnisse:
Personensuche X
?
1

SEOM 2022 clinical guidelines:

Fernández Montes, Ana ; Felip Font, Enriqueta
Clinical and Translational Oncology.  25 (2023)  9 - p. 2625-2626 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Unravelling oligometastatic disease from the perspective of..:

Rodríguez Pérez, Aurora ; Felip Font, Enriqueta ; Chicas-Sett, Rodolfo...
Clinical and Translational Oncology.  25 (2022)  4 - p. 882-896 , 2022
Link: https://doi.org/10.1007/..
 
?
3

SEOM clinical guidelines for the treatment of non-small-cel..:

Trigo Pérez, José Manuel ; Garrido López, Pilar ; Felip Font, Enriqueta.
Clinical and Translational Oncology.  12 (2010)  11 - p. 735-741 , 2010
Link: https://doi.org/10.1007/..
 
?
4

Unravelling oligometastatic disease from the perspective of..:

Conde-Moreno, Antonio José ; González-del-Alba, Aránzazu ; López-Campos, Fernando...
Clinical and Translational Oncology.  25 (2022)  4 - p. 897-911 , 2022
Link: https://doi.org/10.1007/..
 
?
5

SEOM clinical guidelines (2021):

Montes, Ana Fernández ; Font, Enriqueta Felip
Clinical and Translational Oncology.  24 (2022)  4 - p. 611-612 , 2022
Link: https://doi.org/10.1007/..
 
?
6

A Delphi consensus panel about clinical management of early..:

Isla, Dolores ; Felip Font, Enriqueta ; Garrido, Pilar...
Clinical and Translational Oncology;25.  , 2023
Link: https://hdl.handle.net/1..
 
?
7

First-line nivolumab plus ipilimumab for metastatic non-sma..:

Ready, Neal ; Audigier-Valette, Clarisse ; Goldman, Jonathan W...
Journal for ImmunoTherapy of Cancer;11(2).  , 2023
Link: https://hdl.handle.net/1..
 
?
8

Associations of Tissue Tumor Mutational Burden and Mutation..:

Garassino, Marina Chiara ; Novello, S ; Halmos, Balazs...
JTO Clinical and Research Reports;4(1).  , 2023
Link: https://hdl.handle.net/1..
 
?
9

Editorial: Multidisciplinary management of cancer patients ..:

Riveiro Barciela, Maria del Mar ; Felip Font, Enriqueta ; Suarez-Almazor, Maria
Frontiers in Medicine;9.  , 2023
Link: https://hdl.handle.net/1..
 
?
10

Avelumab in Combination With Cetuximab and Chemotherapy as ..:

Andric, Zoran ; Galffy, Gabriella ; Szima, Barna...
JTO Clinical and Research Reports;4(2).  , 2023
Link: https://hdl.handle.net/1..
 
?
11

A Phase 1 Drug-Drug Interaction Study Between Brigatinib an..:

Hanley, Michael J ; D'Arcangelo, Manolo ; Felip Font, Enriqueta...
The Journal of Clinical Pharmacology;63(5).  , 2023
Link: https://hdl.handle.net/1..
 
?
12

Current professional standing of young medical oncologists ..:

Sánchez Martínez, Domingo Antonio ; Quilez‑Cutillas, Aliica ; Jiménez Labaig, Pablo...
Clinical and Translational Oncology;25.  , 2023
Link: https://hdl.handle.net/1..
 
?
13

A transcriptomics approach to expand therapeutic options an..:

Lazar, Vladimir ; Zhang, Baolin ; Magidi, Shai...
Therapeutic Advances in Medical Oncology;15.  , 2023
Link: https://hdl.handle.net/1..
 
?
14

Atezolizumab versus chemotherapy in advanced or metastatic ..:

Peters, S ; Dziadziuszko, Rafal ; Morabito, Alessandro...
Nature Medicine;28.  , 2022
Link: https://hdl.handle.net/1..
 
?
15

High levels of chromosomal aberrations negatively associate..:

Iranzo Gómez, Patricia ; Pardo Aranda, Nuria ; Callejo Perez, Ana...
Journal for ImmunoTherapy of Cancer;10(4).  , 2022
Link: https://hdl.handle.net/1..
 
1-15